financetom
Business
financetom
/
Business
/
Oil Gains on Supply Risks After Ukraine Attack, EIA Sees Prices Falling
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Gains on Supply Risks After Ukraine Attack, EIA Sees Prices Falling
Sep 12, 2025 6:14 AM

08:58 AM EDT, 09/12/2025 (MT Newswires) -- Oil prices rose early Friday, rebounding from the prior day's drop on oversupply worries, after a Ukrainian drone attack on a Russian oil-export port added a fresh risk premium.

West Texas Intermediate crude for October delivery was last seen up $1.38 at $63.75 a barrel, while November Brent oil gained $1.72 to $68.09.

The overnight strike on Russia's Primorsk oil port near St. Petersburg damaged the port and pipeline pumping stations, Bloomberg reported.

While it was unclear whether shipments from the Baltic port would be halted, the attack heightened supply concerns following an Israeli strike earlier this week on Hamas officials in Qatar.

"The support that geopolitical events provide to oil prices is finite. When tensions rise in oil-producing regions such as the Middle East or around Russia, the market's gut reaction is to cover short positions and build up some length. These moves are driven by perceptions, specifically, the belief that not only financial but, more importantly, physical oil supply will be adversely affected," PVM Oil Associates wrote.

The risk premium is offsetting warnings the oil market is over supplied. Both the International Energy Agency and the Energy Information Administration this week warned of rising global inventories as higher production from OPEC+ and producers in the Americas is pushing supply above demand, threatening to push prices lower.

"We expect the Brent crude oil price will decline significantly in the coming months, falling from $68 per barrel in August to $59 per barrel on average in the fourth quarter of 2025 and around $50 per barrel in early 2026," the EIA said in its monthly Short-Term Energy Outlook released Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GreenPower Delivers First BEAST Produced in West Virginia Manufacturing Facility and Updated on Order for 37 BEASTs to be Delivered in 2024 to School Districts in West Virginia
GreenPower Delivers First BEAST Produced in West Virginia Manufacturing Facility and Updated on Order for 37 BEASTs to be Delivered in 2024 to School Districts in West Virginia
Jun 27, 2024
09:05 AM EDT, 06/27/2024 (MT Newswires) -- GreenPower Motor Company Inc. ( GP ) , a manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles, said Thursday it had delivered the first Type D BEAST all-electric, purpose-built, zero-emission school bus manufactured at the company's South Charleston, West Virginia manufacturing plant to the Kanawha County (WV) School District. The...
CrowdStrike Holdings Partners With Distributors to Expand in Latin America
CrowdStrike Holdings Partners With Distributors to Expand in Latin America
Jun 27, 2024
09:05 AM EDT, 06/27/2024 (MT Newswires) -- CrowdStrike Holdings ( CRWD ) said Thursday that it has partnered with technology distributors Ingram Micro, M3Corp, and Tecnologia Especializada Asociada de Mexico to increase adoption of the company's AI-powered Falcon cybersecurity platform across Latin America. Financial details of the partnerships were not disclosed. Price: 380.72, Change: +0.35, Percent Change: +0.09 ...
Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel to ProgenaCare Global
Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel to ProgenaCare Global
Jun 27, 2024
09:04 AM EDT, 06/27/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) said Thursday that it has made its first commercial-scale sale of revyve antimicrobial wound gel product to ProgenaCare Global. Kane said it has now completely fulfilled its obligation related to the US$500,000 initial manufacturing scale up fee that it received upon signing an exclusive distribution agreement for the...
Natera Launches Phase 2 Gastroesophageal Cancer Trial Using Signatera
Natera Launches Phase 2 Gastroesophageal Cancer Trial Using Signatera
Jun 27, 2024
09:04 AM EDT, 06/27/2024 (MT Newswires) -- Natera ( NTRA ) said Thursday it is launching a phase 2 single-arm gastroesophageal cancer trial using Signatera, its tumor-informed molecular residual disease, MRD, test. The study will evaluate the efficacy of trastuzumab deruxtecan in gastroesophageal adenocarcinoma patients in the adjuvant setting, Natera ( NTRA ) said. The company said Signatera will be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved